Krka Eyeing Acquisitions

Slovenian generic drugmaker Krka plans to continue its strong organic growth strategy during 2010, while also eyeing potential takeover opportunities. Chief Executive Jože Colarič told Reuters that the company will remain independent and is assessing potential small- or medium-sized acquisition targets in Europe in order to open up new markets or add new products to its

To read the full article, please choose one of the following options: